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Abstract
Background Neurosurgical management of traumatic brain injury (TBI) is challenging, with only low-quality evidence. We
aimed to explore differences in neurosurgical strategies for TBI across Europe.
Methods A survey was sent to 68 centers participating in the Collaborative European Neurotrauma Effectiveness Research in
Traumatic Brain Injury (CENTER-TBI) study. The questionnaire contained 21 questions, including the decision when to operate
(or not) on traumatic acute subdural hematoma (ASDH) and intracerebral hematoma (ICH), and when to perform a decom-
pressive craniectomy (DC) in raised intracranial pressure (ICP).
Results The survey was completed by 68 centers (100%). On average, 10 neurosurgeons work in each trauma center. In all
centers, a neurosurgeon was available within 30 min. Forty percent of responders reported a thickness or volume threshold for
evacuation of an ASDH. Most responders (78%) decide on a primary DC in evacuating an ASDH during the operation, when
swelling is present. For ICH, 3% would perform an evacuation directly to prevent secondary deterioration and 66% only in case
of clinical deterioration. Most respondents (91%) reported to consider a DC for refractory high ICP. The reported cut-off ICP for
DC in refractory high ICP, however, differed: 60% uses 25 mmHg, 18% 30 mmHg, and 17% 20 mmHg. Treatment strategies
varied substantially between regions, specifically for the threshold for ASDH surgery and DC for refractory raised ICP. Also
within center variation was present: 31% reported variation within the hospital for inserting an ICP monitor and 43% for
evacuating mass lesions.
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Conclusion Despite a homogeneous organization, considerable practice variation exists of neurosurgical strategies for TBI in
Europe. These results provide an incentive for comparative effectiveness research to determine elements of effective neurosur-
gical care.
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Neurosurgical decision-making in patients with traumatic
brain injury (TBI) is often challenging for several reasons.
First, no two TBI patients are identical—clinical and radio-
logical findings may differ greatly [26]. Second, there is no
high-quality evidence to support the range of possible neuro-
surgical procedures in TBI. Indications for surgical manage-
ment are summarized in the Brain Trauma Foundation guide-
lines, [5] but are merely based on retrospective studies of
small groups of selected patients. These guidelines provide
general advice on surgical indications for evacuation of acute
epidural (EDH), acute subdural (ASDH), and contusions/
intracerebral hematomas (ICH) based on the size of the he-
matoma and midline shift. The guidance for decompressive
surgery is even less clear. It is mostly performed to decrease
raised intracranial pressure (ICP), either as a primary proce-
dure in an acute setting, or as a secondary procedure to deal
with diffuse edema or peri-contusional swelling. The guide-
lines state that this latter use of secondary decompression can
reduce ICP, but does not necessarily improve outcome [6].
More fundamentally, the rationale for ICP monitoring has
been challenged by the BEST TRIP randomized controlled
trial (RCT), which found no benefit of a management proto-
col based on intracranial pressure monitoring, compared to
one based on serial imaging and clinical examination. These
results have generated doubts regarding ICP monitoring [1, 7,
15, 20, 28]. Overall, there is no clear consensus on the indi-
cations, extent, and timing of surgery [32].
This limited high-quality evidence for surgical management
in TBI arises from a lack of RCTs, which may be difficult to
conduct due to pragmatic, ethical, and methodological barriers
[3]; however, observational studies to determine effectiveness are
more prone for bias [2]. A promising alternative approach could
be comparative effectiveness research (CER) [24, 33]. In this
design, the heterogeneity and variability, that trouble RCTs in
TBI, are accepted and exploited to study effectiveness of treat-
ments as they occur in real-life practice. The current
Collaborative European Neurotrauma Effectiveness Research in
Traumatic Brain Injury (CENTER-TBI) study aims to use CER
methodology to study treatment effectiveness of several neuro-
surgical interventions [25].
The aim of this study was to explore differences in neuro-
surgical strategies for TBI across Europe to provide a context
for CENTER-TBI, an up-to-date insight into European neuro-
surgical management of TBI, and to identify naturally
occurring variation between trauma centers in order to identify
substrates for neurosurgical research questions that might be
answered using CER in the study.
Materials and methods
This study was conducted within the setting of the internation-
al observational study CENTER-TBI [25]. Between 2014 and
2015, all centers participating in the international multicenter
observational study CENTER-TBI (www.CENTER-TBI.eu)
were asked to complete a questionnaire on neurosurgical
management of TBI (Supplementary file 1) [9]. The
questionnaire was sent to 71 centers (Fig. 1), of which five
centers dropped out and two joined in, resulting in 68 eligible
centers from Austria (n = 2), Belgium (n = 4), Bosnia
Herzegovina (n = 2), Denmark (n = 2), Finland (n = 2),
France (n = 7), Germany (n = 4), Hungary (n = 3), Israel (n =
2), Italy (n = 10), Latvia (n = 3), Lithuania (n = 2), Norway
(n = 3), Romania (n = 1), Serbia (n = 1), Spain (n = 4),
Sweden (n = 2), Switzerland (n = 1), The Netherlands (n = 6)
, and The United Kingdom (n = 7).
Questionnaire development and administration
We developed a set of questionnaires based on available liter-
ature and experts to measure the structure and processes of
TBI care in individual centers. Details regarding this process
and the questionnaires used are described in a separate paper
[9]. Pilot testing was undertaken in 16 of the participating
centers and feedback was incorporated into the final design.
One of the questionnaires was on neurosurgical standard
practice. This survey contained 21 questions which could
broadly be divided into 3 categories: (1) center characteristics
and internal structure; (2) general (neuro) surgical trauma care
and processes; and (3) site specific neurosurgical management
for treating ASDH, EDH, ICH, the use of DC, and policy with
regard to orthopedic injuries in the context of patients who had
suffered a TBI.
Questions either sought quantitative estimates of keymetrics
(e.g., annual surgical volume, staff size, ASDH thickness, or
ICP thresholds for surgery) or attempted to elicit the Bgeneral
policy^ of the center. To capture the latter, these questions were
formulated in two ways: respondents were asked to
436 Acta Neurochir (2019) 161:435–449
estimate what the management strategy is in more than three
quarters of patients in their center in a given context; or respon-
dents were asked to indicate how often they used a particular
surgical technique or how often specific factors influence their
decision-making (never = 0–10%, rarely = 10–30%, some-
times = 30–70%, frequently = 70–90%, and always 90–
100%). The options Bfrequently^ and Balways^ were
interpreted as Bgeneral policy ,^ in line with a previous report
[17] and similar to previous publications on other question-
naires [8, 9].
The reliability of the surveys was tested by calculation of
concordance in a previous publication [9]. Overall, the median
concordance rates between duplicate questions were 0.81
(range 0.44–0.97) and specifically for the BNeurosurgery^
survey 0.78 (range 0.68–0.86).
Analyses
The median and interquartile range (IQR) were calculated for
continuous variables, and frequencies were reported along
with percentages for categorical variables. Countries were di-
vided into seven geographic regions: Northern Europe
(Norway 3, Sweden 2, Finland 2 and Denmark 2 centers),
Western Europe (Austria 2, Belgium 4, France 7, Germany
Fig. 1 Centers and countries included in the Collaborative European
NeuroTrauma Effectiveness Research in Traumatic Brain Injury
(CENTER-TBI) study. Reprinted and updated from Cnossen et al.
(2016) with permission from Dr. Cnossen and Maas et al. (2015).
Collaborative European NeuroTrauma Effectiveness Research in
Traumatic Brain Injury: a prospective longitudinal observational study.
Neurosurgery, 76:67–80, under a CC BY license, with permission from
professor A.I. Maas
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4, Switzerland 1 and The Netherlands 6 centers), The United
Kingdom (7 centers), Southern Europe (Italy 10 and Spain 4
centers), Eastern Europe (Hungary 3, Romania 1, Serbia 1 and
Bosnia Herzegovina 2 centers), Baltic States (Latvia 3 and
Lithuania 2 centers), and Israel (2 centers).
For the following neurosurgical treatment strategies, we
quantified regional differences: an absolute cutoff of hemato-
ma thickness as an indication for surgery for ASDH, DC in the
primary evacuation of an ASDH, early/pre-emptive surgical
evacuation for ICH, and DC as a general policy in case of
refractory raised ICP.
To assess the association of region with one of these treat-
ment choices, a logistic regression was performed with treat-
ment choice (general policy or Byes/no^) as a dependent var-
iable and the region (categorical) as independent variable.
Nagelkerke R2 indicated the variance explained by geograph-
ic region. Analyses were done in IBM SPSS Statistics version
20 (IBM, Chicago, IL, USA).
Results
Center characteristics
All 68 eligible centers completed the questionnaire on neuro-
surgery (response rate 100%). Questionnaires were mainly
completed by neurosurgeons (n = 53, 78%), followed by local
CENTER-TBI investigators (mainly research physicians or
nurses: 19%). On average, 10 neurosurgeons (IQR 8–13)
and four trauma surgeons (IQR 0–12) worked in each center.
All centers reported that neurosurgical coverage was available
24 h a day/7 days a week, either by way of in-house availabil-
ity of a qualified neurosurgeon (47%), or the availability of
such an individual in less than 30 min (53%) (Table 1).
General (neuro) surgical care and processes
Treatment decisions regarding cranial surgical interventions in
TBI patients within the critical care ER and ICU period are in
most centers determined by the neurosurgeon (n = 65, 96%),
followed by the orthopedic surgeons and neuro-intensivist in
respectively 3% (n = 2) and 1% (n = 1). Urgent neurosurgical
interventions (ICP monitor device insertion not included) for
life-threatening traumatic intracranial lesions, are made by the
neurosurgeon in 98.5% and trauma surgeons in 1.5% of the
centers. Raised ICP will almost always be incorporated in
decision-making, the time of day almost never (Fig. 2).
With regard to extremity fractures, the general policy in 59
(87%) centers was so-called damage control with priority for
TBI and delayed definitive treatment of the limb fractures
(Table 2). This policy is protocolized in 21 centers (22%).
Of all centers, 58 (85%) estimated the space-occupying
effect of traumatic lesions on the surrounding tissue by
Table 1 Characteristics of centers participating in neurosurgery survey
Characteristic N
completed
No. (%) or
median
(IQR)
Profession of respondent 68
Neurologist 3 (4)
Neurosurgeon 53 (78)
Trauma surgeon 3 (4)
ED physician 1 (2)
Intensivist 1 (1)a
Administrative staff member 11 (16)a
CENTER-TBI local investigator 13 (19)a
Volume of surgeries in 2013c
ASDH 59 25 (15–49)
ICH/contusion 58 10 (5–21)
EDH 59 10 (5–19)
DC
Hemicraniectomy 57 10 (5–16)
Bifrontal 57 0 (0–2)
Removal bone flap 55 1 (0–3)
Ventriculostomy 57 7 (2–21)
Cranioplasty 56 10 (6–14)
Depressed skull fracture 57 5 (2–12)
Staffing (FTE)
Neurosurgeons 66 10 (8–13)
Residents in training 65 5 (3–8)
Residents not in training 61 0 (0–3)
Trauma surgeons 64 4 (0–12)
Organization of care
Neurosurgical decision making in
ICU
68
Neurosurgeon 65 (96)
Trauma surgeon 1 (3)
Neurologist 0
Neurointensivist or general intensivist 1 (2)
24/7 neurosurgical coverageb 68
Qualified neurosurgeon in-house 32 (47)
Resident neurosurgery in-house 30 (44)
Neurosurgeon within 30 min 36 (53)
Neurosurgical resident within 30 min 11 (16)
Neurosurgeon more than 30 min 0 (0)
ASDH acute subdural hematoma, EDH epidural hematoma, ICH intrace-
rebral hematoma, DC decompressive craniectomy, FTE full time equiv-
alent, ICU intensive care unit
a Numbers do not add up because the local investigators also depicted
their profession and one responder declared to be an intensivist as well as
an administrative staff member
bMultiple options possible
c Head trauma–related surgeries
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calculation of the thickness of the hematoma and midline shift
on CT. A quarter of centers used actual volume measurement
to make surgical decisions (Table 2).
Neurosurgical management of ASDH, EDH, ICH,
and the use of decompressive craniectomy
ASDH provided the highest volume of neurosurgical TBI
cases, on average 25 cases per year. When performing a DC
(for any indication), hemicraniectomy was the preferential
technique, and bifrontal craniectomy was rarely performed
(Table 1). Less than half of the centers (n = 27, 40%) reported
an absolute threshold for evacuating an ASDH. Four out of 10
centers generally incorporate age in their decision for evacu-
ating an ASDH (Table 2 and Fig. 2).
ICH were seldom operated upon pre-emptively, but 67% of
centers reported undertaking delayed surgery in the event of
deterioration. Almost a third of centers reported within-center
variations between individual neurosurgeons in decisions re-
garding surgical evacuation of contusions or traumatic ICH.
Only a very low proportion of centers would routinely
perform a DC at the time of evacuation of either ASDH or
ICH (respectively 6% and 1.5% of the centers). For refrac-
tory raised ICP, most centers (n = 64, 91%) would consider
a decompressive craniectomy, while 32 (47%) see this as a
general policy in their center (Fig. 3, Table 2 and figure in
supplementary file 2). Ninety-six percent (n = 65) reported
to have a specific threshold for DC in refractory raised ICP.
This was most commonly specified as 25 mmHg (n = 39,
58%), followed by 30 mmHg (n = 12, 18%) and 20 mmHg
(n = 11, 17%).
Guidelines and practice variation
Overall, the reported adherence to the BTF guidelines was
high (Fig. 4). The use of surgical interventions and specific
indications for these interventions varied substantially within
and between regions (Table 3). Surgical evacuation of ICH
was only performed in the Baltic States and Southern
Europe and geographic region explained 35% of the variance
in use of the intervention. Having a specific threshold for
ASDH surgery and employing a DC for refractory-raised
ICP showed the largest within-region and also between-
region variation. Lastly, when directly asked whether variation
in specific management strategies exist, respectively 31% and
43% indicated to have a structural variation within their center
staff with regard to ICP sensor insertion and mass lesion evac-
uation (Table 4).
Discussion
The aim of this study was to explore differences in neurosur-
gical strategies for TBI across Europe. We found substantial
variability in practice and thereby provide useful indications
regarding potential substrates for CER in CENTER-TBI. The
structures and processes of neurosurgical care are generally
homogeneous across centers with a comparable number of
neurosurgeons, similar organization of neurosurgical cover-
age and uniform organization of responsibility for most surgi-
cal decisions on the ER and ICU. The indications for surgery,
however, differ substantially with high within-region and
between-region practice variations.
Fig. 2 Factors of influence on neurosurgical decision-making. Shown are
the percentages of centers that would be never/rarely, sometimes or
frequently/always influenced by the described factors in the decision to
perform neurosurgical procedures. Question was completed by all 68
centers. ICP: intracranial pressure; ED: Emergency Department B Other
factors were not predetermined but were specified by responders
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Table 2 Neurosurgical treatment policy of traumatic brain injury
Characteristic N completed No. (%) or mean (sd)
Structural estimation of mass lesions on CTa 68
Visual intuition (e.g., no actual measurement) 27 (40)
Width, diameter and/or amount of MLS of the mass lesion 58 (85)
Volume measurements with imaging software 11 (16)
Volume measurements with direct calculation 17 (25)
Other 1 (2)
ASDH operation determinants
Age considered important in surgery decisiond 68 26 (42)
Size (volume or thickness) threshold for surgery 68 27 (40)
Minimum volume or thickness: 28b
15 mm 2 (3)
10 mm 16 (24)
10 mm and/or > 5 mm MLS 2 (3)
5 mm 3 (4)
ASDH thickness > width of cranium 3 (4)
Midline shift > thickness ASDH 2 (3)
DC indications 68
Routine 4 (6)
Intra-operative brain swelling 59 (86)
Sometimes as a second procedure in case of uncontrollable ICP 5 (7)
Never 0 (0)
ICH/contusion operation determinants
General policy 68
Pre-emptive (to prevent deterioration) 2 (3)
Delayed (after deterioration) 45 (66)
Variable (depends on surgeon) 18 (27)
Other 3 (4)
DC indications 68
Routine 1 (2)
Intra-operative brain swelling 55 (81)
Sometimes as a delayed procedure in case of uncontrollable ICP 10 (15)
Never 2 (3)
Raised ICP determinants
DC employed > 70% of refractory high ICP cases 68 32 (46)
Mostly early DC (within 6–12 h of refractory ICP) 64 32 (47)
Mostly late DC (as last resort to control ICP) 64 32 (47)
ICP threshold for DC 68 65 (96)
Raised ICP threshold for DC (mmHg): 64c
30 12 (18)
25 39 (60)
20 11 (17)
15 1 (2)
Not standardized 1 (2)
DC indications considereda
Pre-emptive in raised ICP (not last resort) 7 (10)
Refractory raised ICP (last resort) 68 64 (91)
CT evidence of raised ICP 9 (13)
Intra-operative brain swelling 45 (66)
Routine with every ASDH or ICH evacuation 2 (3)
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Contemporary neurosurgical care
There are no recent comparable studies providing an overview
of neurosurgical management on this scale. Two recent na-
tional surveys, in The United Kingdom and the Republic of
Ireland and The Netherlands, have shown a comparable vari-
ability among neurosurgeons regarding the decision to evac-
uate an ASDH or to perform a primary DC [21, 34].
When comparing our results to existing—much older—sur-
veys, evacuation of a traumatic ICH seems to be less often con-
sidered than in the past [11, 30]. Our results are concordant with
older surveys in reporting variable use of DC for refractory raised
ICP, despite the DECRA trial (the RECUEicp was not published
yet) [12, 19]. Interestingly, although the mostly applied cutoff for
DC in refractory is reported to be 25 mmHg (60%), a lower
value, 20 mmHg, and a higher value, 30 mmHg, are both report-
ed to be used in almost 20% of centers.
More broadly, our results replicate past data that suggest
poor guideline adherence and practice variability. Rayan
et al. showed that in only 17% of a random sample of
(brain) trauma patients care was delivered according to
the BTF guidelines [31]. Of note, in the current study,
surveys were sent to the centers between 2014 and 2015,
so the more recent, updated BTF guidelines were not pub-
lished yet, although the update was for medical manage-
ment mainly (except DC in refractory IC) [6].
Fig. 3 Treatment indications for neurosurgical interventions. Shown are
the proportions of centers that generally have these specific preferences
with regard to operating or not in ASDH, ICH, and raised intracranial
pressure, respectively. ASDH: acute subdural hematoma; DC:
decompressive craniectomy; ICH: intracerebral hematoma; ICP:
intracranial pressure
Table 2 (continued)
Characteristic N completed No. (%) or mean (sd)
Policy towards extremity limb fracturese
Damage control 59 (87)
Definitive care 68 9 (13)
MLS midline shift, BTF Brain Trauma Foundation, ICP intracranial pressure, hrs hours
aMultiple options possible
b One responder did not report a threshold for surgery while answering a specific threshold (10 mm)
cOne responder reported to employ a threshold for DC in raised ICP while not giving their specific threshold
d The question was whether the responder considers if the decision on surgery in acute SDH is influenced by age (based on a general consensus in their
respective center)
e Damage control is focused on the TBI. All extremity fractures are stabilized, but definitive treatment delayed. Definitive care: the extremity fractures are
operated as soon as possible
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Comparable questionnaires on other aspects of TBI care
have recently been published for ER and ICU management
that, without exception, show practice variation [8, 9, 14, 18].
Practice variation has also been reported for other life-
threatening or emergency disorders including ruptured ab-
dominal aneurysm [4] and the spontaneous intracerebral hem-
orrhage [16].
Strengths and limitations
A strength of the current study is the methodology that we
used to investigate practice variation. First, detailed questions
were posed to shed light on specific clinical decisions with
regard to neurosurgical interventions. Subsequently,
(objective) answers on amounts (volume load, mostly from
in-hospital registries) were combined with qualitative infor-
mation (estimations of general policies, using two ap-
proaches). When integrated with the high response rate and
low amount of missing data in 68 centers, this overview pro-
vides a complete picture of reported neurosurgical care across
Europe.
This study also had weaknesses. First, responses to the
questionnaire may have been biased by the abstract nature of
the questions posed, which neglected to provide a more con-
crete clinical context for judgments about reported practice.
Although the respondents were experienced neurosurgeons
with a scientific background, the difficulty of weighing indi-
vidual patient characteristics with potentially fatal conse-
quences can never be fully captured by a theoretical survey.
In particular, the rational decision-making can obviously be
completely different due to the cognitive biases of neurosur-
geons in the acute critical care period.
Second, there might be a concern as to how well the indi-
vidual neurosurgeon respondent can represent the general cen-
ter neurosurgical policy. Although we urged the respondent to
report the general consensus on treatment at their center rather
than individual management preferences (see Supplementary
file 1), neurosurgical strategies may still be variable within
centers between neurosurgeons; however, we did capture a
qualitative assessment of this intra-center variability
(Table 4). Third, we did not fully account for inherent regional
variations such as evidence knowledge, caseload, and case-
mix due to referral patterns or admission policies, as a poten-
tial explanation for differences in neurosurgery policies.
Variations in evidence knowledge for some questions, such
as those on guidelines, are important. Moreover, while we
did asses the center’s caseload and casemix, the caseload
and casemix of the (individual) respondent was not specifical-
ly asked. Fourth, the questions dealt with individual decisions
in isolation, rather than the more complex real-life situation
Table 3 Within- and between-region variation in surgical management
Decision Northern
Europe
Western
Europe
United
Kingdom
Southern
Europe
Eastern
Europe
Baltic
States
Israel Nagelkerke R2
value
ASDH
- Size threshold for evacuation 56 29 0 29 71 80 100 0.34
- Routine or intraoperative DC
ICH/contusion
89 92 100 100 86 80 100 0.17
- Pre-emptive surgery Refractory
raised ICP
0 0 0 7 0 20 0 0.35
- DC 44 37 29 57 43 80 100 0.15
ASDH acute subdural hematoma, ICH intracerebral hematoma, DC decompressive craniectomy, ICP intracranial pressure
Table presents the proportion (%) of respondent within each region that indicated that they used the described strategy as their general policy for patients
with respectively ASDH, ICH, or refractory raised ICP. TheNagelkerke R2 value represents the variation in treatment that can be explained by the region
Fig. 4 BTF guideline adherence. Shown are the percentages of centers
that reported to never/rarely, sometimes or frequently/always follow the
Brain Trauma Foundation guidelines for the management of SDH, EDH,
or contusions. Question was completed by 68 of the 68 centers. TBI:
traumatic brain injury; SDH: subdural hematoma; EDH: epidural
hematoma
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where several competing priorities need to be addressed. Fifth,
the reports may have been biased (in varying extents) towards
how centers would have been liked to be perceived, rather
than a faithful report of actual clinical policy and practice.
This issue will be addressed by a planned comparison of these
Provider Profiling responses with actual treatment strategies
employed in patient-level data from these centers in the
CENTER-TBI Core study.
Finally, our study sample represents centers participating in
TBI-researchwhich are likely specialized neurotrauma centers
with a tendency to have practice that is skewed towards up-to-
date knowledge. An example is the fact that almost half of all
centers stated to have a neurosurgeon in house 24 h a day.
When studying all centers in Europe providing care to TBI
patients, variability might be even larger.
Implications
Our results should be interpreted in combination with the cur-
rent evidence on the effectiveness of different surgical strate-
gies. For the use of DC in refractory raised ICP due to diffuse
swelling, two RCTs have provided useful guidance. The
DECRA trial showed that early use of DC for modest rises
in ICPwas associatedwith worse outcomes [12].More recent-
ly however, after the conduct of this survey, the RESCUEicp
trial showed that, when used for refractory severe intracranial
hypertension, DC can save lives, but results in an excess of
severely disabled survivors [19]. It is clear that the interven-
tion is not uniformly beneficial: while some functional im-
provements occur by 12 months, many survivors remain se-
verely disabled. Rescue-ICP was not published yet at the con-
duct of this study. In our study, the majority of centers indi-
cated that DC is often employed for both indications (pre-
emptive and last resort).
With regard to focal lesions, a recent study suggested that
in patients with an ASDH an aggressive approach towards
evacuation is associated with better outcome compared to a
conservative approach [35]. Similar trends were noted in the
STITCH-trauma trial, which suggested better outcome with
early surgical management of ICH [29]. In our study, a minor-
ity of centers considers an early strategy for ICH evacuation.
Lastly, DC in the primary evacuation of an ASDH seems to
be associated with more favorable outcomes [22]. There is no
class 1 evidence, although the research question is currently
b e i ng ch a l l e ng ed i n an RCT (Re s cu e -ASDH;
ISRCT87370545). In the current survey standard (in some
cases preventive) DC in ASDH evacuation is rarely employed
but mostly done in case of intraoperative swelling.
There may be several explanations for the practice varia-
tion that we observed. Although high practice variation rates
can be a sign of poor implementation of evidence-based care,
in this context it probably reflects the lack of strong evidence
to underpin practice. In such a low evidence context, clinical
decisions are not driven by careful consideration or penetra-
tion of the evidence, but by local customs and surgical train-
ing, handed down over the years from one surgeon to the other
in a given center (or country). The professional cultural drivers
that underpin such learned treatment preferences are resistant
to change, and provide an important hurdle to the design and
conduct of randomized studies for neurosurgical interventions
in TBI [27].
Additionally, even where the results of RCTs are available,
it is possible that many neurosurgeons do not think the RCT
results applicable to their (individual) patients, or restrict their
focus to short term clinical outcomes such as mortality and
complication rates (instead of long-term clinical or patient
reported outcomes). [13]
The results of the questionnaire point out burning clinical
questions for neurosurgery in TBI. For ASDH and ICH, im-
portant questions include whether to operate or not, the timing
of operative evacuation, and whether or not a primary DC
should be undertaken. Future studies should address these
questions. For DC, the variation should lead to studies explor-
ing the lack of evidence penetration, in addition to studying
effectiveness of DC in refractory raised ICP.
While RCTs may provide the security of randomization as
a basis for examining answering these questions, RCTs have
no successful history in TBI due to various reasons [24]. The
CENTER-TBI Provider Profiling exercise has revealed large
practice variation that can be related to variation in patient
outcome [23]. Such a CER approach may be a pragmatic
alternative to RCTs.
Therefore, different steps are required. Firstly, to specify,
ideally a-priori, how and where treatment variation occurs.
This was one of the goals of this provider profiling.
Secondly, the CENTER-TBI Core Study will need to collect
patient-level data from a large variety of centers, capturing the
range of treatment variation and relate it to outcome. The main
challenge is to disentangle the effect of specific surgical strat-
egies in a center from other regional care variation that might
Table 4 Neurosurgical decision making
Characteristic N completed No (%)
Structural variationa ICP monitor insertion 68
No 47 (69)
Yes 21 (31)
Structural variationa mass lesion evacuation 65
No 29 (43)
Yes 29 (43)
Depending on lesion type 7 (10)
ED emergency department, GCS Glasgow Coma Scale
a Structural variation refers to a situation in which one or more of the
clinicians are generally more likely to perform the (diagnostic) interven-
tion than others
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affect outcome. To do so, we propose random-effect models in
which the effect of Bsurgical strategy^ on outcome is estimat-
ed with adjustment for other between-hospital differences in a
random effect for hospital [10, 34, 35].
Conclusions
This survey study explored differences in neurosurgical strat-
egies for TBI. Current neurosurgical care differs within
Europe (and Israel), while the organization of trauma centers
does not. This variation in practice likely reflects the lack of
high-quality evidence for these important, potentially life-sav-
ing, emergency neurosurgical interventions. In addition, local
professional culture may drive practice in ways that are not
dependent on the availability or penetration of evidence. The
resulting entrenched practice variation does not facilitate equi-
poise that makes RCTs easy to deliver. CER may provide a
pragmatic approach to generate evidence on optimal neuro-
surgical strategies for TBI patients.
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